MedPath

Comparison of Vigorous Versus Low Intensity Cool Room Treadmill Training in People with Multiple Sclerosis

Not Applicable
Withdrawn
Conditions
Multiple Sclerosis
Exercise
Neurological Rehabilitation
Neuronal Plasticity
Cooling
Interventions
Other: Body-weight supported treadmill training in a room cooled to 16°C
Registration Number
NCT04175054
Lead Sponsor
Memorial University of Newfoundland
Brief Summary

New research in animal models of MS suggests that greater training intensity is required to restore lost functions. We have developed and tested vigorous intensity cool room treadmill training that people with MS who have fatigue and heat-sensitivity can tolerate. This study will focus on the appropriate dosage of training.

Detailed Description

Our previous research showed that vigorous aerobic training in a room cooled to 16°C can improve walking and measures of brain plasticity among people with MS related walking disability, especially in those who had fatigue and heat sensitivity. As a next step, we will compare our novel vigorous intensity cool room treadmill training to low intensity cool room treadmill walking and determine whether intensity is important in order to improve brain repair and restore walking among people with MS. Our first objective is to compare the effects of 12 weeks of vigorous versus low intensity training on walking. Our second objective is to determine whether treadmill training alters indicators of brain repair. We hypothesize that the cool room vigorous training will result in greater increases in walking and less fatigue, which will be sustained at follow-up. We also hypothesize that improvements will align with less brain inhibition (shortened CSP measured using Transcranial Magnetic Stimulation) and greater upregulation of the neurotrophin IGF-1.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
70
Inclusion Criteria
  • people with a confirmed diagnosis of relapsing-remitting or progressive MS
  • older than 18 and less than 70 years of age
  • able to walk at least 10 meters with use of walking aids (Expanded Disability Status Scale (EDSS) <7.0)
  • must be stable without relapse for at least 90 days
Exclusion Criteria
  • currently attending physical rehabilitation
  • functional community ambulators (gait speed>120 cm/s)
  • a relapse of MS

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Vigorous Intensity GroupBody-weight supported treadmill training in a room cooled to 16°CMore than 60% Heart Rate Reserve
Low Intensity GroupBody-weight supported treadmill training in a room cooled to 16°CLess than 40% Heart Rate Reserve
Primary Outcome Measures
NameTimeMethod
Fast walking speed12 weeks

Gait velocity (cm/s) measured while walking at fast pace

Secondary Outcome Measures
NameTimeMethod
Spatiotemporal parameters of gait measured while walking at self-selected paceFollowing completion of the 12-week exercise intervention and 3-months post-exercise intervention

Walkway outputs include step length and width (cm), double support time (%), symmetry (ratio between affected and less-affected sides)

Maximal oxygen consumption during graded exercise testFollowing completion of the 12-week exercise intervention and 3-months post-exercise intervention

VO2max

Multiple Sclerosis Impact Scale-29Following completion of the 12-week exercise intervention and 3-months post-exercise intervention

The Multiple Sclerosis Impact Scale-29 provides physical and psychological sub-scales. Using a Likert scale, participants indicate the degree to which problems, such as 'moving about' and 'balance' affect them from 'not at all' to 'extremely'.

Hospital Anxiety and Depression ScaleFollowing completion of the 12-week exercise intervention and 3-months post-exercise intervention

A self-reported rating scale of severity of mood symptoms ranging from 0-21 with higher score indicating more symptoms.

Fatigue Severity ScaleFollowing completion of the 12-week exercise intervention and 3-months post-exercise intervention

A 9-item questionnaire, which assesses the severity of fatigue with items scored on a 7-point scale, '1 = strongly disagree' and '7 = strongly agree'. The minimum and maximum score possible are 9 and 63 respectively. Another reporting method is the mean of all scores from all 9-items, with minimum and maximum score possible being 1 and 7 respectively.

Symbol Digit Modality TestFollowing completion of the 12-week exercise intervention and 3-months post-exercise intervention

Cognitive impairment

Serum Insulin-like growth factor-1 (IGF-1)Following completion of the 12-week exercise intervention and 3-months post-exercise intervention

Resting and exercise-induced serum levels of IGF-1 in response to the 12-week exercise intervention

Transcranial Magnetic StimulationFollowing completion of the 12-week exercise intervention and 3-months post-exercise intervention

Corticospinal excitability

Structural and functional brain changes on Magnetic Resonance Imaging (MRI)Following completion of the 12-week exercise intervention and 3-months post-exercise intervention

Standardized protocol recommended by the Canadian Dementia Imaging Group (https://www.cdip-pcid.ca/) which includes T1 and T2-weighted structural images, diffusion tensor imaging, and resting state connectivity.

Montreal Cognitive AssessmentFollowing completion of the 12-week exercise intervention and 3-months post-exercise intervention

Measures overall cognitive function with score ranging from 0 to 30 with higher scores indicating higher executive function

Trial Locations

Locations (1)

Memorial University of Newfoundland

🇨🇦

St. John's, Newfoundland and Labrador, Canada

© Copyright 2025. All Rights Reserved by MedPath